论文部分内容阅读
目的:探讨中西医结合治疗肺癌的临床疗效及安全性。方法:选取56例临床确诊为肺癌的患者,随机分为对照组和治疗组各28例,对照组采用单纯西医治疗,治疗组采用中西医结合治疗,两组均连续治疗3个月,观察两组临床疗效及安全性。结果:两组患者经治疗后,临床症状得到缓解,其中对照组总有效率为53.6%,治疗组总有效率为78.6%,治疗组总有效率明显高于对照组,差异具有统计学意义(P<0.05);对照组不良反应发生率为71.4%,治疗组不良反应发生率为46.4%,治疗组明显低于对照组,差异具有统计学意义(P<0.05)。结论:中西医结合治疗肺癌,疗效较好,不良反应发生率低,患者较容易接受,是一种值得推广的治疗方法。
Objective: To explore the clinical efficacy and safety of integrated traditional Chinese and western medicine in the treatment of lung cancer. Methods: Fifty-six patients with clinically diagnosed lung cancer were randomly divided into control group and treatment group, 28 cases in each group. The control group was treated with Western medicine alone. The treatment group was treated with integrated traditional and western medicine. Both groups were treated for 3 months. Group clinical efficacy and safety. Results: After treatment, the clinical symptoms were relieved in both groups. The total effective rate was 53.6% in the control group and 78.6% in the treatment group. The total effective rate in the treatment group was significantly higher than that in the control group (the difference was statistically significant ( P <0.05). The incidence of adverse reactions in the control group was 71.4%, and the incidence of adverse reactions in the treatment group was 46.4%. The treatment group was significantly lower than the control group. The difference was statistically significant (P <0.05). Conclusion: Integrative Chinese and Western medicine treatment of lung cancer, the effect is good, the incidence of adverse reactions is low, patients are more acceptable, is a worthy of promotion of treatment.